The deal, for about $14 billion, is expected to be announced in the coming days, before Merck holds an investor briefing in Boston on Tuesday. Bayer is expected to pay cash and also swap some assets to complete the transaction.
via NYT > Business Day http://ift.tt/1fyi7IH
via WordPress http://ift.tt/R5EJ7P
No comments:
Post a Comment